Clinical Trials Browser

Phase 3 × Has results × nimotuzumab × Clear all

NCT02395016 2024-04-04

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Phase 3 Completed

90 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms